UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 81

Sortiert nach

Pelvic exenteration: Ten-year experience at the European Institute of Oncology in Milan

Gynecologic oncology, 2009-07, Vol.114 (1), p.64-68

2009

Volltextzugriff (PDF)

Rectosigmoid resection at the time of primary cytoreduction for advanced ovarian cancer. A multi-center analysis of surgical and oncological outcomes

Gynecologic oncology, 2012-08, Vol.126 (2), p.220-223

2012

Volltextzugriff (PDF)

Endometriosis-Related Ovarian Cancers: Evidence for a Dichotomy in the Histogenesis of the Two Associated Histotypes

Diagnostics (Basel), 2023-04, Vol.13 (8), p.1425

2023

Volltextzugriff (PDF)

Reproductive Outcomes and Fertility Preservation Strategies in Women with Malignant Ovarian Germ Cell Tumors after Fertility Sparing Surgery

Biomedicines, 2020-11, Vol.8 (12), p.554

2020

Volltextzugriff (PDF)

Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups

Journal of Gynecologic Oncology, 2020, 31(6), , pp.1-13

2020

Volltextzugriff (PDF)

The role of restaging borderline ovarian tumors: Single institution experience and review of the literature

Gynecologic oncology, 2010-11, Vol.119 (2), p.274-277

2010

Volltextzugriff (PDF)

Robotic Surgery: Changing the Surgical Approach for Endometrial Cancer in a Referral Cancer Center

Journal of minimally invasive gynecology, 2009-07, Vol.16 (4), p.427-431

2009

Volltextzugriff (PDF)

Myxoid leiomyosarcoma of the ovary: a very uncommon finding

International journal of gynecological cancer, 2024-02, Vol.34 (2), p.346-348

2024

Volltextzugriff (PDF)

Accuracy of computed tomography and magnetic resonance imaging in the detection of lymph node involvement in cervix carcinoma

European radiology, 2005-12, Vol.15 (12), p.2469-2474

2005

Volltextzugriff (PDF)

Management of recurrent ovarian cancer: when platinum-based regimens are not a therapeutic option

International journal of gynecological cancer, 2019-11, Vol.29 (9), p.1431-1436

2019

Volltextzugriff (PDF)

Sentinel lymph node biopsy in open surgery for gynecological malignancies

International journal of gynecological cancer, 2023-04, Vol.33 (4), p.636-637

2023

Volltextzugriff (PDF)

Fertility preservation in women with cervical cancer

Critical reviews in oncology/hematology, 2020-10, Vol.154, p.103092-103092, Article 103092

2020

Volltextzugriff (PDF)

What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome

European journal of surgical oncology, 2020-05, Vol.46 (5), p.888-892

2020

Volltextzugriff (PDF)

Fertility sparing surgery in sex-cord stromal tumors: oncological and reproductive outcomes

International journal of gynecological cancer, 2022-08, Vol.32 (8), p.1063-1070

2022

Volltextzugriff (PDF)

Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort

Clinical nuclear medicine, 2022-03, Vol.47 (3), p.e221

2022

Volltextzugriff (PDF)

Stage I juvenile granulosa cell tumors of the ovary: A multicentre analysis from the MITO-9 study

European journal of surgical oncology, 2021-07, Vol.47 (7), p.1705-1709

2021

Volltextzugriff (PDF)

Experimental drugs for fallopian cancer: promising agents in the clinical trials and key stumbling blocks for researchers

Expert opinion on investigational drugs, 2022-12, Vol.31 (12), p.1339-1357

2022

Volltextzugriff (PDF)

Multidisciplinary approach in the management of advanced ovarian cancer patients: A personalized approach. Results from a specialized ovarian cancer unit

Gynecologic oncology, 2017-03, Vol.144 (3), p.468-473

2017

Volltextzugriff (PDF)

2022-RA-1557-ESGO Mesenteric lymph node involvement in patients undergoing a bowel resection during debulking surgery in advanced ovarian cancer

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A349-A349

2022

Volltextzugriff (PDF)

2022-RA-1072-ESGO Optimal cytoreduction for advanced epithelial ovarian cancer: non invasive predictive factors

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A294-A294

2022

Volltextzugriff (PDF)

780 Treatment of ovarian cancer cells with olaparib and trabectedin modulates the expression of immune-related molecules and the killing ability of TCR-edited T cells

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A504-A504

2024

Volltextzugriff (PDF)

1037 Adoptive cell therapy with genetically engineered t-cells for epithelial ovarian cancer

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A511-A511

2024

Volltextzugriff (PDF)

610 Non-invasive predictive factors of complete cytoreduction at interval debulking surgery in advanced epithelial ovarian cancer

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A350-A350

2024

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(81)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pelvic exenteration: Ten-year experience at the European Institute of Oncology in Milan

Rectosigmoid resection at the time of primary cytoreduction for advanced ovarian cancer. A multi-center analysis of surgical and oncological outcomes

Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells

Endometriosis-Related Ovarian Cancers: Evidence for a Dichotomy in the Histogenesis of the Two Associated Histotypes

Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness

Reproductive Outcomes and Fertility Preservation Strategies in Women with Malignant Ovarian Germ Cell Tumors after Fertility Sparing Surgery

Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups

The role of restaging borderline ovarian tumors: Single institution experience and review of the literature

Robotic Surgery: Changing the Surgical Approach for Endometrial Cancer in a Referral Cancer Center

Myxoid leiomyosarcoma of the ovary: a very uncommon finding

Accuracy of computed tomography and magnetic resonance imaging in the detection of lymph node involvement in cervix carcinoma

Management of recurrent ovarian cancer: when platinum-based regimens are not a therapeutic option

Sentinel lymph node biopsy in open surgery for gynecological malignancies

Fertility preservation in women with cervical cancer

What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome

Fertility sparing surgery in sex-cord stromal tumors: oncological and reproductive outcomes

Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort

Stage I juvenile granulosa cell tumors of the ovary: A multicentre analysis from the MITO-9 study

Experimental drugs for fallopian cancer: promising agents in the clinical trials and key stumbling blocks for researchers

Multidisciplinary approach in the management of advanced ovarian cancer patients: A personalized approach. Results from a specialized ovarian cancer unit

2022-RA-1557-ESGO Mesenteric lymph node involvement in patients undergoing a bowel resection during debulking surgery in advanced ovarian cancer

2022-RA-1072-ESGO Optimal cytoreduction for advanced epithelial ovarian cancer: non invasive predictive factors

780 Treatment of ovarian cancer cells with olaparib and trabectedin modulates the expression of immune-related molecules and the killing ability of TCR-edited T cells

1037 Adoptive cell therapy with genetically engineered t-cells for epithelial ovarian cancer

610 Non-invasive predictive factors of complete cytoreduction at interval debulking surgery in advanced epithelial ovarian cancer

Suchergebnisse filtern